Functional mode of action of ASP5736, a selective 5-HT5A receptor antagonist for treatment of cognitive dysfunction in schizophrenia
| Autor: | Svensson, T.H., Yamazaki, M., Yamamoto, N., Yarimizu, J., Okabe, M., Moriyama, A., Furutani, M., Marcus, M., Harada, K. |
|---|---|
| Zdroj: | In European Neuropsychopharmacology 2019 29 Supplement 1:S414-S415 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect